T3 Companies’s Eli Lilly LLY Stock Holding History

T3 Companies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-230	Closed	-$247K	–	204
2025 Q4	$247K	Buy	+230	New	+$220K	0.31%	66

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T3 Companies's LLY Position: Q1 2026 in Review

T3 Companies sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 230 shares — an estimated $247K sold.

T3 Companies first reported a position in LLY in Q4 2025 and held it in 1 quarter. The position peaked at $247K in Q4 2025. 4,373 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

T3 Companies reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
T3 Companies sold 230 Eli Lilly shares in Q1 2026, an estimated $247K.
T3 Companies first reported a position in Eli Lilly in Q4 2025 and held it in 1 quarter.
T3 Companies's Eli Lilly position peaked at $247K in Q4 2025.
4,373 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on T3 Companies's 13F filing for Q1 2026, filed 7 May 2026.